Barclays Boosts Phibro Animal Health (NASDAQ:PAHC) Price Target to $22.00
Phibro Animal Health (NASDAQ:PAHC – Free Report) had its price objective raised by Barclays from $20.00 to $22.00 in a research report report published on Monday morning,Benzinga reports. The firm currently has an underweight rating on the stock. Several other research firms have also recently commented on PAHC. Morgan Stanley upped their price target on […]
![Barclays Boosts Phibro Animal Health (NASDAQ:PAHC) Price Target to $22.00](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/phibro-animal-health-co-logo.png?v=20221209141115&w=240&h=240&zc=2)